Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Lactium, a milk protein, can help reduce symptoms of skin disorders linked to stress and anxiety without side effects.

Tigason improved hair growth in a boy with monilethrix without side effects.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Accurate diagnosis of SLE requires extensive testing due to its complex symptoms.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

Tofacitinib helped a woman regrow hair with no major side effects.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Pediatric systemic lupus erythematosus is a severe autoimmune disease in children requiring early diagnosis and comprehensive management.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.